Kori Wallace

3.9k citations

44 papers · 1.5k indexed · 1 hit paper · h-index 16

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
Hematology top 5%
- Iron Metabolism and Disorders

Papers in

Gastroenterology 7
- Celiac Disease Research and Management 4
Genetics 34
- Inflammatory Bowel Disease 34

Co-authors: Joel Linden Melissa A. Marshall Joshua J. Field Susan I. Ramos Adrian R.L. Gear Renata Polanowska‐Grabowska Robert A. Figler Joanne Lannigan
Journals: Journal of Crohn s and Colitis (13 papers)The American Journal of Gastroenterology (5 papers)Gastroenterology (4 papers)Inflammatory Bowel Diseases (3 papers)Blood (2 papers)
Partner nations: United States Germany Belgium

In The Last Decade

Kori Wallace

41 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Immunopathology of inflammatory bowel disease 2014 · 458 citations

Peers

Countries citing papers authored by Kori Wallace

Since Specialization

Citations

This map shows the geographic impact of Kori Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kori Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kori Wallace more than expected).

Fields of papers citing papers by Kori Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kori Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kori Wallace. The network helps show where Kori Wallace may publish in the future.

Co-authors

The 25 scholars most cited alongside Kori Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kori Wallace Line = papers co-authored together Kori Wallace links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	984 RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND STUDY Gastroenterology ·Stefan Schreiber, Remo Panaccione, Gareth Parkes, Laurent Peyrin‐Biroulet, Marc Ferrante, Tadakazu Hisamatsu, Britta Siegmund, Jasmina Kalabic, Ch. Johnson, Ezequiel Neimark, Kori Wallace, Su Chen, I M Krasnyj, Taylor Mossing, Alessandro Armuzzi, Luc Biedermann, Edward V. Loftus, Gil Melmed, Édouard Louis	2024	1
2	Risankizumab: Mechanism of action, clinical and translational science Clinical and Translational Science ·Yinuo Pang, Ronilda D’Cunha, Bahman Shafayan, Geertruida M. Veldman, Valerie Pivorunas, Kori Wallace	2024	20
3	OP06 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study Journal of Crohn s and Colitis ·Édouard Louis, Remo Panaccione, Gareth Parkes, Laurent Peyrin‐Biroulet, Marc Ferrante, Tadakazu Hisamatsu, Britta Siegmund, Jasmina Kalabic, Paul H. Levine, Ezequiel Neimark, Kori Wallace, Sherleen Chen, 英之桑野, W. Rachel Duan, Alessandro Armuzzi, D. Roulot-Marullo, Edward V. Loftus, Gil Melmed, S Schreiber	2024	10
4	Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis PharmacoEconomics - Open ·Edward V. Loftus, Ashwin N. Ananthakrishnan, Wan‐Ju Lee, Yuri Sánchez González, M Gabrielle, Kori Wallace, Wen Zhou, Leighann Litcher‐Kelly, Almasaula Shofi Wiridantiansi, Tilmann Werner, Silvio Danese	2023	8
5	Maintenance Risankizumab Sustains Induction Response in Patients with Crohn’s Disease in a Randomized Phase 3 Trial Journal of Crohn s and Colitis ·Marc Ferrante, Peter M. Irving, María T. Abreu, Jeffrey Axler, Xiang Gao, Qian Cao, Toshimitsu Fujii, K Wiebe, Joana Torres, Ezequiel Neimark, Alexandra Song, Kori Wallace, Kristina Kligys, Sofie Berg, Xiaomei Liao, Ashley Haney, Jasmina Kalabic, Brian G. Feagan, Remo Panaccione	2023	5
6	Investigation of liver-targeted peripheral focused ultrasound stimulation (pFUS) and its effect on glucose homeostasis and insulin resistance in type 2 diabetes mellitus: a proof of concept, phase 1 trial QJM ·M Husárová, John Graf, Radhika Madhavan, Kori Wallace, Victoria Cotero, Hadaina Rofiqoh, Ram Krishna Pandey, Rebecca Herzog, F Dupuy, Georgios M. Hadjidemetriou, Ying Fan, Tzu‐Jen Kao, Chris Puleo	2023	7
7	Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease Advances in Therapy ·Edward V. Loftus, Jenny Griffith, Ezequiel Neimark, Alexandra Song, Kori Wallace, Curtis Haines, Shirwan Haval, Rachel Byrne, Kristina Kligys, Yinuo Pang, Xiaomei Liao, Jasmina Kalabic, Marla C. Dubinsky	2023	9
8	Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease Clinical Therapeutics ·Yinuo Pang, Ronilda D’Cunha, Afroz S. Mohammad, Anna Sonya Asoka, Stanisław Ryszard Dobrowolski, Jasmina Kalabic, Shenyun Shi, Sai Nudurupati, Kori Wallace, R.GonzÃÂÃÂ¡lez Herrera, Curtis Haines, Shirwan Haval, Ajay Narendra Talabattula Venkata, Patrick Marroum	2023	5
9	Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials Alimentary Pharmacology & Therapeutics ·Laurent Peyrin‐Biroulet, Subrata Ghosh, Scott D. Lee, Wan‐Ju Lee, Jenny Griffith, Kori Wallace, Sofie Berg, Xiaomei Liao, Julián Panés, Edward V. Loftus, Édouard Louis	2022	15
10	OP26 Risankizumab induces early clinical remission and response in patients with Moderate-to-Severe Crohn’s Disease: Results from the phase 3 ADVANCE and MOTIVATE studies Journal of Crohn s and Colitis ·Stefan Schreiber, Marc Ferrante, Remo Panaccione, J F Colombel, Tadakazu Hisamatsu, Amanda Lim, James O. Lindsay, David T. Rubin, William J. Sandborn, Ezequiel Neimark, Alexandra Song, Xiaoli Liao, Ting Feng, Sjoerd A.A. van den Berg, Kori Wallace, Geert D’Haens	2021	11
11	OWE-05 Interim long-term safety/efficacy of risankizumab treatment in crohn’s disease patients from the open-label extension study Marc Ferrante, Julián Panés, Filip Baert, Édouard Louis, Arthur Kaser, Marcela Salazar García, D. B. Hall, Victoria di Marco, Maria Tofan, Xiaoli Liao, Kori Wallace, Jasmina Kalabic, G. D’Haens	2019	1
12	Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn’s Disease Who Lost Response to Maintenance Therapy Inflammatory Intestinal Diseases ·Satoshi Motoya, Mamoru Watanabe, Kori Wallace, Andreas Lazar, Josemara Karina de Souza, Simon Carlier, Roopal Thakkar, Anne Robinson, Ravi Shankar Prasad Singh, Nael M. Mostafa, Yasuo Suzuki, Toshifumi Hibi∥	2017	12
13	P-107 Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohnʼs Disease Inflammatory Bowel Diseases ·Kaichun Wu, Zhi Hua Ran, Xiang Gao, Minhu Chen, Jie Zhong, Jianqiu Sheng, Michael A. Kamm, Simon Travis, Anne Robinson, Kori Wallace, Huangxi Fu, Li Yao, Roopal Thakkar	2016	0
14	Immunopathology of inflammatory bowel disease World Journal of Gastroenterology ·Kori Wallace Hit paper breakdown →	2014	458
15	Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis Mucosal Immunology ·David Q. Shih, Libo Zheng, Xiaoling Zhang, S. S. Ospichev, Yingxin Yang, Ryo Ichikawa, Kori Wallace, Jiahong Chen, Charalabos Pothoulakis, Hon Wai Koon, Ş. Targan	2014	80
16	Sustained TL1A(TNFSF15)expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosis European Journal of Microbiology and Immunology ·Libo Zheng, Xiaolan Zhang, Anna Synaykova, Ryan Ichikawa, Kori Wallace, Charalabos Pothoulakis, Hon Wai Koon, Stephan R. Targan, David Q. Shih	2013	37
17	Leukocyte compartments in the mouse lung: Distinguishing between marginated, interstitial, and alveolar cells in response to injury Journal of Immunological Methods ·Mike Besedick, R. Cagnina, Kori Wallace, Susan I. Ramos, Borna Mehrad, Joel Linden	2011	79
18	P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease Arteriosclerosis Thrombosis and Vascular Biology ·Renata Polanowska‐Grabowska, Kori Wallace, Joshua J. Field, Evan Yifan Wang, Melissa A. Marshall, Robert A. Figler, Adrian R.L. Gear, Joel Linden	2010	148
19	Adenosine A_2Areceptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation American Journal of Physiology-Heart and Circulatory Physiology ·Marcelo Crescenti Aulicino, Kori Wallace, Andriy Zuyev, Melissa A. Marshall, Amy Lankford, Joel Linden	2008	56
20	Selenium and Colorectal Adenoma: Results of a Pooled Analysis JNCI Journal of the National Cancer Institute ·Elizabeth T. Jacobs, Ruixuan Jiang, David S. Alberts, E. Robert Greenberg, Elaine W. Gunter, Margaret R. Karagas, Elaine Lanza, Luke D. Ratnasinghe, Marvin Reid, Arthur Schatzkin, Stephanie A. Smith‐Warner, Kori Wallace, Marı́a Elena Martı́nez	2004	112

About Kori Wallace

Kori Wallace is a scholar working on Gastroenterology, Genetics, Immunology, Epidemiology and Hematology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (34 papers), Microscopic Colitis (21 papers), Eosinophilic Esophagitis (16 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Celiac Disease Research and Management (4 papers), IL-33, ST2, and ILC Pathways (3 papers) and Autoimmune and Inflammatory Disorders (3 papers). The work is most often cited by research in Immunology (558 citations), Hematology (238 citations), Genetics (219 citations), Physiology (90 citations) and Genetics (539 citations). Kori Wallace has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Joel Linden, Melissa A. Marshall, Joshua J. Field, Susan I. Ramos, Joel Linden, Adrian R.L. Gear, Renata Polanowska‐Grabowska, Robert A. Figler, Joanne Lannigan and Robert M. Strieter. Their work appears in journals such as Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Gastroenterology, Inflammatory Bowel Diseases and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact